Through the myocardial infarction model developed, it demonstrated nebivolol’s enhancement of NO-mediated effects such as the prevention of nitrosative damages through the reduction in the activity of iNOS, preservation of the glomerular filtration rate through neuronal NOS (nNOS), and restoration of eNOS in the late period of MI. This evidence concerns the gene NOS1 and myocardial infarction.